We are supporting an exciting project that exploits the role and vulnerabilities of circulating tumor cell clusters, major mediators of metastasis. The team is developing an entirely novel concept in cancer therapeutics, aiming to generate novel anti-cancer agents targeting circulating tumor cell clusters, leading to blockage of cancer progression. They are now looking for experienced and highly ambitious individuals as potential team members, advisors, future board members with drug development and/or commercial/BD background to kick off the next steps moving the project into the commercial setting.

If interested, please contact Stephan Emmerth.

Share this article

View all news

Sign up to receive our newsletter in your inbox.